| Financial Year |
March 31 2023 |
| Monetary Funds |
202,165,984.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
14,556,987.48 |
| Advances to Suppliers |
107,200.79 |
| Other Receivables |
3,629,825.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
22,036,934.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
657,224,049.64 |
| Other Current Assets |
38,284,519.97 |
| Total Current Assets |
958,230,454.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
128,422,765.22 |
| Long-term Equity Investment |
29,398,409.60 |
| Investment Properties |
173,216.66 |
| Fixed Assetes |
130,558,396.83 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,793.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,163,442.18 |
| Other Non-Current Assets |
560,441,064.13 |
| Sub-Total of Non-Current Assets |
1,568,049,022.80 |
| Total Assets |
2,526,279,477.32 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
86,997,434.32 |
| Accounts Received In Advance |
83,850.84 |
| Employee Compensation Payable |
3,762,550.23 |
| Taxes Payable |
11,304,138.92 |
| Interest Payable |
-- |
| Dividend Payable |
485,999.47 |
| Other payables |
144,147,939.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,452,136.37 |
| Other Current Liabilities |
401,020,521.34 |
| Sub-Total of Current Liabilities |
750,890,652.48 |
| Long-term Loans |
80,644,155.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
665,000.00 |
| Deferred Income Tax Liabilities |
5,021,886.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
106,318,048.52 |
| Total Liabilities |
857,208,701.00 |
| Paid-In Capital(Or Share Stock) |
477,381,905.00 |
| Capital Surplus |
27,897,075.75 |
| Surplus Reserve |
228,152,201.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
916,592,345.69 |
| Minority Stockholder's Interest |
17,550,132.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,651,520,643.37 |
| Owner's Equity（Stockholder's Equity） |
1,669,070,776.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,526,279,477.32 |
